Form 8-K - Current report:
SEC Accession No. 0001193125-21-316076
Filing Date
2021-11-02
Accepted
2021-11-02 06:10:07
Documents
12
Period of Report
2021-11-02
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d242523d8k.htm   iXBRL 8-K 22421
  Complete submission text file 0001193125-21-316076.txt   140551

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA teva-20211102.xsd EX-101.SCH 2894
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20211102_lab.xml EX-101.LAB 17305
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20211102_pre.xml EX-101.PRE 10930
5 EXTRACTED XBRL INSTANCE DOCUMENT d242523d8k_htm.xml XML 3422
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16174 | Film No.: 211369155
SIC: 2834 Pharmaceutical Preparations